HEN2 Inhibitors
HEN2 inhibitors are a class of chemical compounds that target and inhibit the activity of the HEN2 (Hydroxyaryl Enzyme 2) enzyme, a protein involved in various biochemical processes, including signal transduction and metabolic regulation. These inhibitors typically function by binding to the active site of the enzyme or interfering with its cofactor binding, effectively reducing its catalytic activity. The inhibition of HEN2 leads to a cascade of downstream effects within the biological systems in which the enzyme plays a key role, often affecting pathways related to cellular metabolism or signaling. Chemically, HEN2 inhibitors may vary widely in their structure, ranging from small organic molecules with specific binding motifs that recognize and attach to the enzyme's active site, to larger, more complex structures that modulate enzyme activity indirectly by interacting with allosteric sites.
The mechanism of inhibition by HEN2 inhibitors can be either reversible or irreversible. In reversible inhibition, the inhibitor binds non-covalently to the enzyme, allowing for the normal function of the enzyme to resume once the inhibitor is removed. In contrast, irreversible inhibitors form a covalent bond with the enzyme, permanently altering its structure and function. Structural analyses, such as X-ray crystallography or NMR, are commonly used to study the binding interactions between HEN2 inhibitors and their target enzyme, providing insights into how structural modifications can enhance inhibitory potency or selectivity. Furthermore, these compounds are often optimized through various rounds of chemical modifications to improve their binding affinity, stability, and specificity for the HEN2 enzyme. The development of HEN2 inhibitors contributes to a deeper understanding of the enzyme's role in fundamental biochemical processes, as well as the broader implications of its regulation in living organisms.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA sequences at the transcription initiation complex, blocking the elongation phase of RNA synthesis by RNA polymerase, which would downregulate the transcription of the HEN2 gene. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin specifically inhibits RNA polymerase II, leading to a sharp decrease in the transcription of mRNA coding for proteins like HEN2, causing a reduction in its mRNA levels and subsequently its protein abundance. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Cordycepin acts by prematurely terminating mRNA elongation due to its incorporation into the growing RNA chain, which would lead to a truncated and nonfunctional mRNA transcript of the HEN2 gene. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide disrupts the transcriptional machinery by binding to the XPB subunit of TFIIH, leading to inhibition of RNA polymerase II-mediated transcription and a consequent decrease in HEN2 mRNA synthesis. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB interferes with the phosphorylation of the carboxy-terminal domain of RNA polymerase II, which is essential for the initiation and elongation phases of transcription, resulting in the downregulation of HEN2 expression. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Leptomycin B inhibits the nuclear export of mRNA by binding to exportin 1, which would reduce the cytoplasmic levels of HEN2 mRNA available for translation, thereby decreasing the expression of the HEN2 protein. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $63.00 $110.00 $214.00 | 1 | |
Ribavirin mimics the nucleoside guanosine, which can lead to the inhibition of RNA-dependent RNA polymerase activity, ultimately reducing the replication and transcription of RNA, including the transcripts of the HEN2 gene. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin can inhibit topoisomerase II, an enzyme involved in DNA replication and transcription, which could lead to a decrease in HEN2 gene expression due to disrupted DNA and RNA synthesis processes. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic acid depletes guanosine nucleotide pools by inhibiting inosine monophosphate dehydrogenase, which is critical for the synthesis of mRNA; this would result in decreased levels of HEN2 mRNA. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Flavopiridol suppresses cyclin-dependent kinases that are necessary for the phosphorylation of RNA polymerase II, leading to the inhibition of transcriptional elongation and a consequent decrease in HEN2 gene expression. | ||||||